Squarepoint’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Buy |
+49,392
| New | +$112K | ﹤0.01% | 2477 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2842 |
|
|
2024
Q3 | – | Sell |
-198,840
| Closed | -$243K | – | 2622 |
|
|
2024
Q2 | $243K | Sell |
198,840
-11,311
| -5% | -$13.8K | ﹤0.01% | 2061 |
|
|
2024
Q1 | $458K | Buy |
210,151
+59,618
| +40% | +$130K | ﹤0.01% | 1715 |
|
|
2023
Q4 | $233K | Sell |
150,533
-23,092
| -13% | -$35.8K | ﹤0.01% | 2065 |
|
|
2023
Q3 | $224K | Sell |
173,625
-10,869
| -6% | -$14K | ﹤0.01% | 2062 |
|
|
2023
Q2 | $317K | Buy |
184,494
+135,638
| +278% | +$233K | ﹤0.01% | 1838 |
|
|
2023
Q1 | $73.8K | Buy |
+48,856
| New | +$73.8K | ﹤0.01% | 2072 |
|
|
2022
Q4 | – | Sell |
-10,523
| Closed | -$15K | – | 2314 |
|
|
2022
Q3 | $15K | Sell |
10,523
-36,160
| -77% | -$51.5K | ﹤0.01% | 2010 |
|
|
2022
Q2 | $85K | Sell |
46,683
-60,078
| -56% | -$109K | ﹤0.01% | 1895 |
|
|
2022
Q1 | $285K | Buy |
106,761
+68,812
| +181% | +$184K | ﹤0.01% | 1761 |
|
|
2021
Q4 | $164K | Sell |
37,949
-1,769
| -4% | -$7.65K | ﹤0.01% | 2172 |
|
|
2021
Q3 | $202K | Sell |
39,718
-708,569
| -95% | -$3.6M | ﹤0.01% | 1821 |
|
|
2021
Q2 | $4.74M | Buy |
748,287
+666,574
| +816% | +$4.22M | 0.02% | 485 |
|
|
2021
Q1 | $632K | Buy |
81,713
+4,905
| +6% | +$37.9K | ﹤0.01% | 1374 |
|
|
2020
Q4 | $503K | Buy |
76,808
+38,065
| +98% | +$249K | ﹤0.01% | 1500 |
|
|
2020
Q3 | $258K | Sell |
38,743
-76,921
| -67% | -$512K | ﹤0.01% | 1791 |
|
|
2020
Q2 | $963K | Buy |
115,664
+103,473
| +849% | +$862K | 0.02% | 958 |
|
|
2020
Q1 | $94K | Sell |
12,191
-136,362
| -92% | -$1.05M | ﹤0.01% | 1643 |
|
|
2019
Q4 | $1.23M | Sell |
148,553
-52,451
| -26% | -$436K | 0.01% | 1188 |
|
|
2019
Q3 | $1.48M | Buy |
201,004
+106,280
| +112% | +$784K | 0.01% | 956 |
|
|
2019
Q2 | $1.06M | Sell |
94,724
-42,064
| -31% | -$472K | 0.01% | 1211 |
|
|
2019
Q1 | $1.47M | Buy |
136,788
+57,004
| +71% | +$613K | 0.02% | 904 |
|
|
2018
Q4 | $1.21M | Sell |
79,784
-9,879
| -11% | -$149K | 0.01% | 836 |
|
|
2018
Q3 | $1.66M | Buy |
89,663
+24,191
| +37% | +$448K | 0.02% | 788 |
|
|
2018
Q2 | $1.5M | Buy |
65,472
+39,124
| +148% | +$895K | 0.02% | 737 |
|
|
2018
Q1 | $750K | Buy |
26,348
+3,511
| +15% | +$99.9K | 0.01% | 919 |
|
|
2017
Q4 | $482K | Buy |
22,837
+9,637
| +73% | +$203K | 0.01% | 1224 |
|
|
2017
Q3 | $240K | Sell |
13,200
-2,800
| -18% | -$50.9K | ﹤0.01% | 1272 |
|
|
2017
Q2 | $248K | Buy |
+16,000
| New | +$248K | ﹤0.01% | 1211 |
|
|
2017
Q1 | – | Sell |
-16,360
| Closed | -$180K | – | 1568 |
|
|
2016
Q4 | $180K | Buy |
+16,360
| New | +$180K | 0.01% | 1475 |
|